12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Friday's after-market session. Notable gainers included Apollomics (APLM), GRI Bio (GRI), Syros Pharmaceuticals (SYRS), TC BioPharm (TCBP), Renalytix (RNLX), and Moleculin Biotech (MBRX). On the other hand, Motus GI Hldgs (MOTS), RVL Pharmaceuticals (RVLP), Intelligent Bio Solutions (INBS), CervoMed (CRVO), OpGen (OPGN), and SeaStar Medical Holding (ICU) saw their stock prices decrease.
October 20, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CervoMed's stock fell 7.68% to $10.47.
The fall in CervoMed's stock price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SeaStar Medical Holding's shares decreased by 6.87% to $0.95.
The decrease in SeaStar Medical Holding's shares suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Intelligent Bio Solutions' stock declined by 8.93% to $0.25.
The decline in Intelligent Bio Solutions' stock indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Motus GI Hldgs' stock decreased by 14.8% to $0.41 during Friday's after-market session.
The significant decrease in Motus GI Hldgs' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
OpGen's shares decreased by 7.1% to $0.71.
The decrease in OpGen's shares suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
RVL Pharmaceuticals' shares decreased by 10.64% to $0.03.
The decrease in RVL Pharmaceuticals' shares suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Apollomics' stock increased by 23.6% to $2.15 during Friday's after-market session.
The significant increase in Apollomics' stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
GRI Bio's stock increased by 11.39% to $1.27.
The increase in GRI Bio's stock price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Moleculin Biotech's stock moved upwards by 6.3% to $0.63.
The upward movement in Moleculin Biotech's stock indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Renalytix's stock rose 6.8% to $1.3.
The rise in Renalytix's stock price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Syros Pharmaceuticals' shares moved upwards by 8.14% to $2.39.
The upward movement in Syros Pharmaceuticals' shares indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
TC BioPharm's shares moved upwards by 7.23% to $0.4.
The upward movement in TC BioPharm's shares indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100